Evidence map›Paper›PMID 22089440›Full record

ReviewThe American journal of clinical nutrition2011

Micronutrients in HIV/AIDS: is there evidence to change the WHO 2003 recommendations?

Janet E Forrester, Kevin A Sztam

Abstract readReview
In one paragraph

Review in The American journal of clinical nutrition, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Micronutrient supplementation in adults with HIV infection.The Cochrane database of systematic reviews · 2017
    Pooled it
  2. Micronutrient supplementation in pregnant women with HIV infection.The Cochrane database of systematic reviews · 2012
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Janet E ForresterDepartment of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA 02111, USA. janet.forrester@tufts.edu
Kevin A Sztam
Boston Children's Hospital · USTufts University · US

Funding

Nutrition and Metabolism CoreP30DA013868 · NIDA · TUFTS UNIVERSITY BOSTON · PI WANKE, CHRISTINE A · 2002 to 2012
$10.0M
NUTRITIONAL STATUS IN HIV POSITIVE HISPANIC DRUG ABUSERSR01DA011598 · NIDA · TUFTS UNIVERSITY BOSTON · PI FORRESTER, JANET E · 1999 to 2008
$5.9M
Micronutrient Metabolism in HIV+and HIV-Drug UsersR01DA014501 · NIDA · TUFTS UNIVERSITY BOSTON · PI FORRESTER, JANET E · 2002 to 2004
$1.2M
NIDA NIH HHS 5 P30 DA013868NIDA NIH HHS DA 11598NIDA NIH HHS DA14501
6 · The paper itself

Abstract

To establish whether there is new evidence to inform changes to WHO 2003 recommendations for micronutrient intake in persons with HIV/AIDS, we conducted a narrative review of the literature published from 2003 to 2010. Although the review focused on new randomized controlled trials of multiple micronutrients in HIV-infected adults, including pregnant and lactating women, we also considered randomized trials of single micronutrients. The review found that there are few published randomized controlled trials of micronutrients in HIV-infected persons and that most trials used high-dose multiple micronutrient supplementation. The trials were heterogeneous with respect to the composition and dose of micronutrients used and the target population studied. Despite this heterogeneity, 5 of 6 trials that used high-dose multiple micronutrients showed benefits in terms of either improved CD4 cell counts or survival. However, many of these trials were small and of short duration, and therefore the long-term risks and benefits of high-dose multiple micronutrients are not established. The current WHO recommendation for an intake of micronutrients at Recommended Dietary Allowance amounts continues to be a reasonable target for persons with clinically stable HIV infection. In light of new data that show adverse effects of high-dose vitamin A, the current recommendation for a single high dose of vitamin A in HIV-infected women within 6 wk of delivery should be reviewed.

Indexed as

Dietary SupplementsPractice Guidelines as TopicAcquired Immunodeficiency SyndromeAdultCD4 Lymphocyte CountFemaleHIV InfectionsHumansLactationMicronutrientsNutrition PolicyPregnancyPregnancy Complications, InfectiousTreatment OutcomeVitamin AWorld Health OrganizationMicronutrientsVitamin A

Identifiers

PMID22089440
PMCPMC3226021
OpenAlexW2054809800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.